Barrett's EsophagusCancerGut health
What this study is
To assess the effect of ablative therapy (Photodynamic Therapy or Radiofrequency ablation ) on Barrett's Esophagus
What's being tested
- Biopsy
Intervention · OTHER
Biopsies for research purposes will be obtained when returning for clinically indicated surveillance of Barrett's Esophagus
Study details
- Sponsor
- Mayo Clinic
- Conditions
- Barrett's Esophagus · Early Esophageal Adenocarcinoma
- Enrolling
- 600 people
- Starts
- 2004-01
- Est. completion
- 2029-01
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 90 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patients who have had or qualify for ablation therapy for treatment of their barrett's esophagus with high grade dysplasia or early esophageal adenocarcinoma
- Ability to provide informed consent
You can't join if
- Eastern Cooperative Oncology Group performance status 3 or 4
- Inability to tolerate endoscopic procedures
- Pregnancy: Females of child-bearing age will be screened with pregnancy test.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openMayo Clinic
Rochester, Minnesota, United States
Study team
Sponsor
Mayo Clinic
Study ID 258-04
Principal investigator
Cadman Leggett, MD
Mayo Clinic
Have questions? The record lists no central contact. Use Consider me and the site team can reach you, or find them through ClinicalTrials.gov ↗.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.